PAVAN, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 1.949
AS - Asia 1.787
EU - Europa 943
AF - Africa 235
SA - Sud America 234
Continente sconosciuto - Info sul continente non disponibili 31
OC - Oceania 20
Totale 5.199
Nazione #
US - Stati Uniti d'America 1.786
SG - Singapore 520
CN - Cina 389
IT - Italia 355
VN - Vietnam 293
HK - Hong Kong 146
BR - Brasile 144
DE - Germania 63
FI - Finlandia 57
BD - Bangladesh 55
NL - Olanda 51
FR - Francia 48
GB - Regno Unito 46
RU - Federazione Russa 45
PL - Polonia 43
IN - India 42
CA - Canada 41
KR - Corea 40
JP - Giappone 36
CI - Costa d'Avorio 30
ES - Italia 27
AR - Argentina 22
ZA - Sudafrica 22
IQ - Iraq 19
SE - Svezia 19
ID - Indonesia 17
MX - Messico 17
PK - Pakistan 17
AT - Austria 16
TR - Turchia 16
PH - Filippine 15
EC - Ecuador 13
TH - Thailandia 13
AE - Emirati Arabi Uniti 12
TN - Tunisia 12
AL - Albania 11
CR - Costa Rica 11
JM - Giamaica 11
TW - Taiwan 11
VE - Venezuela 11
AM - Armenia 10
AZ - Azerbaigian 10
IE - Irlanda 10
MA - Marocco 10
NP - Nepal 10
PT - Portogallo 10
UA - Ucraina 10
AO - Angola 9
BA - Bosnia-Erzegovina 9
BB - Barbados 9
IR - Iran 9
MY - Malesia 9
SA - Arabia Saudita 9
SK - Slovacchia (Repubblica Slovacca) 9
UY - Uruguay 9
UZ - Uzbekistan 9
BJ - Benin 8
CH - Svizzera 8
CL - Cile 8
EG - Egitto 8
KZ - Kazakistan 8
MT - Malta 8
CG - Congo 7
CO - Colombia 7
CY - Cipro 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
HT - Haiti 7
HU - Ungheria 7
LA - Repubblica Popolare Democratica del Laos 7
MK - Macedonia 7
PS - Palestinian Territory 7
TT - Trinidad e Tobago 7
AU - Australia 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
GH - Ghana 6
GN - Guinea 6
GP - Guadalupe 6
GR - Grecia 6
HN - Honduras 6
JO - Giordania 6
LB - Libano 6
LC - Santa Lucia 6
MD - Moldavia 6
MZ - Mozambico 6
NE - Niger 6
NO - Norvegia 6
PY - Paraguay 6
TJ - Tagikistan 6
UG - Uganda 6
AF - Afghanistan, Repubblica islamica di 5
BE - Belgio 5
BG - Bulgaria 5
BS - Bahamas 5
BZ - Belize 5
CM - Camerun 5
EE - Estonia 5
GA - Gabon 5
HR - Croazia 5
Totale 4.971
Città #
Ashburn 358
San Jose 302
Singapore 287
Hong Kong 130
Santa Clara 119
Ho Chi Minh City 106
Beijing 83
Council Bluffs 80
Chandler 57
Padova 55
Hanoi 52
Hefei 50
Los Angeles 47
New York 39
The Dalles 38
Helsinki 36
Columbus 34
Abidjan 30
Chicago 30
Bytom 28
Rome 28
Seoul 28
Boardman 27
Padua 24
Da Nang 20
Dallas 19
Houston 18
Milan 18
Munich 18
Lauterbourg 17
Fairfield 16
Ogden 16
Haiphong 15
Washington 15
Orem 14
Tokyo 14
Johannesburg 11
London 11
São Paulo 11
Warsaw 11
Baku 10
Lappeenranta 10
San Diego 10
Baghdad 9
Bangkok 9
Barcelona 9
Bologna 9
Buffalo 9
Dublin 9
Montreal 9
Seattle 9
Thái Bình 9
Bến Tre 8
Cotonou 8
Guangzhou 8
Montevideo 8
Quito 8
Rio de Janeiro 8
Shanghai 8
Turku 8
Vienna 8
Xewkija 8
Atlanta 7
Belo Horizonte 7
Biên Hòa 7
Bridgetown 7
Brooklyn 7
Frankfurt am Main 7
Luanda 7
Paris 7
Phoenix 7
San José 7
Stockholm 7
Tashkent 7
Amman 6
Ankara 6
Boston 6
Brazzaville 6
Castries 6
Conakry 6
Dushanbe 6
Jakarta 6
Kampala 6
Les Abymes 6
Maputo 6
Mascalucia 6
Medford 6
Naples 6
Niamey 6
Prague 6
Santiago 6
Woodbridge 6
Yerevan 6
Accra 5
Antananarivo 5
Brescia 5
Cagliari 5
Cambridge 5
Camerino 5
Denver 5
Totale 2.736
Nome #
1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluation 310
A new inactive conformation of SARS-CoV-2 main protease 296
IDENTIFICATION OF NEW SARS-COV-2 MAIN PROTEASE INHIBITORS BY AN INTEGRATED IN-SILICO AND IN-VITRO STRATEGY 277
A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1 delta 254
Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease Mpro 253
Qualitative Estimation of Protein-Ligand Complex Stability through Thermal Titration Molecular Dynamics Simulations 247
Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma 241
“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies 240
Tackling the COVID-19 pandemic through the combination of established and novel Computer-Aided Drug Discovery workflows 227
Investigating RNA-protein recognition mechanisms through supervised molecular dynamics (SuMD) simulations 217
Computational Strategies to Identify New Drug Candidates against Neuroinflammation 209
The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective? 208
From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19? 206
Inspecting the Mechanism of Fragment Hits Binding on SARS‐CoV‐2 M pro by Using Supervised Molecular Dynamics (SuMD) Simulations 205
SARS-CoV-2 3CLpro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376 200
Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332 197
Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)? 192
Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir 192
Implementing a Scoring Function Based on Interaction Fingerprint for Autogrow4: Protein Kinase CK1δ as a Case Study 188
Ribose and Non-Ribose A2A Adenosine Receptor Agonists: Do They Share the Same Receptor Recognition Mechanism? 187
Sodium or Not Sodium: Should Its Presence Affect the Accuracy of Pose Prediction in Docking {GPCR} Antagonists? 175
Thermal Titration Molecular Dynamics (TTMD): Not Your Usual Post-Docking Refinement 174
Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics 156
Streptogramin A derivatives as mitochondrial translation inhibitors to suppress glioblastoma stem cell growth 148
Totale 5.199
Categoria #
all - tutte 16.134
article - articoli 14.837
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.971


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202293 0 0 0 0 3 1 15 11 34 7 7 15
2022/2023197 18 1 2 12 24 17 2 42 30 16 22 11
2023/2024376 15 34 67 26 52 23 39 27 27 20 20 26
2024/2025950 17 74 45 41 121 45 48 91 96 39 133 200
2025/20263.136 222 252 423 373 291 143 429 307 308 176 98 114
2026/2027446 104 131 117 94 0 0 0 0 0 0 0 0
Totale 5.199